SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-041069
Filing Date
2021-02-12
Accepted
2021-02-12 14:13:28
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND VI GP MANAGER, LTDOMEGA FUND VI GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G d125141dsc13g.htm SC 13G 134764
2 EX-99.1 d125141dex991.htm EX-99.1 7275
3 EX-99.2 d125141dex992.htm EX-99.2 11484
  Complete submission text file 0001193125-21-041069.txt   155179
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Subject) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91617 | Film No.: 21625597
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund VI, L.P. (Filed by) CIK: 0001757917 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G